dmso l carnitine 99.9 % L-CARNITINE 3000 MG (EU) –

Impact of L-carnitine on imatinib-related muscle cramps in patients with Gastrointestinal stromal tumor

Res 3 , 9498 (2015)

Calabro, F.J

in: PubMed | Google Scholar | Published October 16, 2025 - More info Long-chain fatty acid oxidation disorders (LC-FAODs) cause energy deficits in heart and skeletal muscle that are only partially corrected by current medium-chain lipid therapies such as triheptanoin

[DOI] [PubMed] [Google Scholar] Schrder C.H., Edefonti A., Fischbach M., Klaus G., Rnnholm K., Schaefer F., Simkova E., Stefanidis D., Strazdins V., Vande Walle J., Watson A., Zurowska A

The intended ARTHS mutation was dominantly represented in MiSeq reads (Table S3)